HLA class I and class II antibodies: monitoring before and after kidney transplantation and their clinical relevance.
about
Sensitive solid-phase detection of donor-specific antibodies as an aid highly relevant to improving allograft outcomes.Flow cytometric detection of complement-activating HLA antibodies.Long-Term Effects of Antibodies against Human Leukocyte Antigens Detected by Flow Cytometry in the First Year after Renal Transplantation.Novel solid phase-based ELISA assays contribute to an improved detection of anti-HLA antibodies and to an increased reliability of pre- and post-transplant crossmatching.HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP.Donor-specific antibodies require preactivated immune system to harm renal transplant.Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR,DQ,DP epitopes.Regulation of HLA class II expression prevents allogeneic T-cell responses.Long-term follow up for anti-HLA donor specific antibodies postrenal transplantation: high immunogenicity of HLA class II graft molecules.ELISA methods detect HLA antibodies with variable sensitivity.Screening for WBC antibodies by lymphocyte indirect immunofluorescence flow cytometry: superior to cytotoxicity and ELISA?An extended lymphocytotoxicity test for patients treated with lymphocytotoxic antibodies.Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
P2860
Q30317554-0C403D8B-F4F0-4C3C-8D49-F332E929B352Q33207800-033DB488-89AF-48D1-B0F8-612E5DC87404Q33974428-E418E292-3D97-4A58-9992-44636750088AQ35574072-9AD7C177-2DA2-41EE-B372-48771E34C721Q36858319-E25262D5-366D-45F2-841D-F36396118251Q37149941-D09FBC8D-D491-4592-A605-747182E14F27Q37300446-DA12CF93-D90E-4CF8-A520-107FB41C4FAFQ39620423-8ACEE040-EE0A-4A31-B858-484156C6B458Q47272995-8519890F-649B-45AC-B49A-4FA85B8235D6Q51197852-3ED372CA-A46B-439A-9B47-9D3DEC89F370Q52862440-19CBE4E9-84C2-4969-8C5A-90E2981BF225Q52970963-FD284D9D-E553-4420-95BE-EC0179D52B19Q53570974-AEA40E51-E88D-4A89-A11F-FE39E48BD5A7
P2860
HLA class I and class II antibodies: monitoring before and after kidney transplantation and their clinical relevance.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
HLA class I and class II antib ...... and their clinical relevance.
@en
HLA class I and class II antib ...... and their clinical relevance.
@nl
type
label
HLA class I and class II antib ...... and their clinical relevance.
@en
HLA class I and class II antib ...... and their clinical relevance.
@nl
prefLabel
HLA class I and class II antib ...... and their clinical relevance.
@en
HLA class I and class II antib ...... and their clinical relevance.
@nl
P2093
P1433
P1476
HLA class I and class II antib ...... and their clinical relevance.
@en
P2093
P304
P356
10.1097/00007890-199806150-00024
P577
1998-06-01T00:00:00Z